CA Patent

CA2907152A1 — Fusion proteins and methods thereof

Assigned to Columbia University in the City of New York · Expires 2014-09-25 · 12y expired

What this patent protects

The invention discloses oncogenic fusion proteins. The invention provides methods for treating gene-fusion based cancers.

USPTO Abstract

The invention discloses oncogenic fusion proteins. The invention provides methods for treating gene-fusion based cancers.

Drugs covered by this patent

Patent Metadata

Patent number
CA2907152A1
Jurisdiction
CA
Classification
—
Expires
2014-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Columbia University in the City of New York
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.